help button home button
AJRCMB
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yang, X.
Right arrow Articles by Morrell, N. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yang, X.
Right arrow Articles by Morrell, N. W.
American Journal of Respiratory Cell and Molecular Biology. Vol. 27, pp. 688-696, 2002
© 2002 American Thoracic Society
DOI: 10.1165/rcmb.2002-0067OC

Hypoxic Induction of Cox-2 Regulates Proliferation of Human Pulmonary Artery Smooth Muscle Cells

Xudong Yang, Karen K. K. Sheares, N. Davie, Paul D. Upton, Graham W. Taylor, Jo Horsley, John Wharton and Nicholas W. Morrell

Department of Medicine, University of Cambridge School of Clinical Medicine, Addenbrooke's and Papworth Hospitals, Cambridge; and Section on Clinical Pharmacology, Faculty of Medicine, Imperial College, Hammersmith Hospital, London, United Kingdom

Address correspondence to: Dr. Nicholas W. Morrell, Department of Medicine, University of Cambridge School of Clinical Medicine, Addenbrooke's Hospital, Box 157, Hills Road, Cambridge CB2 2QQ, UK. E-mail: nwm23{at}cam.ac.uk

Chronic hypoxia-induced pulmonary hypertension results partly from proliferation of smooth muscle cells in small peripheral pulmonary arteries. Therefore, we examined the effect of hypoxia on growth of pulmonary artery smooth muscle cells (PASMCs) from human distal pulmonary arteries. Initial studies identified that serum-induced proliferation of explant-derived PASMCs was inhibited under hypoxic conditions (3–4 kPa in medium). However, selection of hypoxia-stimulated cells was achieved by culturing cells at low density under conditions of prolonged hypoxia (1–2 wk). In hypoxia-inhibited and -stimulated cells, Western blotting revealed hypoxic induction of cyclooxygenase (COX)-2, which was dependent on the activation of p38MAPK, but not COX-1, inducible nitric oxide synthase (iNOS), or hemoxygenase-1 (HO-1). Hypoxic induction of COX-2 was also observed in the media of pulmonary arteries in lung organ culture. Hypoxia induced a 4- to 5-fold increase (P < 0.001) in prostaglandin (PG)E2, PGD2, PGF2{alpha}, and 6-keto-PGF1{alpha} release from PASMCs. Hypoxic inhibition of proliferation was attenuated by incubation with indomethacin (10 µM), or the COX-2 antagonist, NS398 (10 µM), but not by the COX-1 antagonist, valeryl salicylate (0.5 mM). In conclusion, we have isolated cells from human peripheral pulmonary arteries that are either inhibited or stimulated by culture under hypoxic conditions. In both cell types hypoxia modulates cell proliferation by induction of COX-2 and production of antiproliferative prostaglandins. Induction of COX-2 may contribute to the inhibition of hypoxia-induced pulmonary vascular remodeling.

Abbreviations: carbon monoxide, CO • cyclooxygenase, COX • Dulbecco's modified Eagle's medium, DMEM • fetal bovine serum, FBS • heme oxygenase-1, HO-1 • interleukin, IL • inducible nitric oxide synthase, iNOS • nitric oxide, NO • pulmonary artery smooth muscle cells, PASMCs • prostaglandin, PG • S-Nitroso-N-acetylpenicillamine, SNAP • valeryl salicylate, VS




This article has been cited by other articles:


Home page
 CirculationHome page
L. E. Fredenburgh, O. D. Liang, A. A. Macias, T. R. Polte, X. Liu, D. F. Riascos, S. W. Chung, S. L. Schissel, D. E. Ingber, S. A. Mitsialis, et al.
Absence of Cyclooxygenase-2 Exacerbates Hypoxia-Induced Pulmonary Hypertension and Enhances Contractility of Vascular Smooth Muscle Cells
Circulation, April 22, 2008; 117(16): 2114 - 2122.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
N. El-Bizri, L. Wang, S. L. Merklinger, C. Guignabert, T. Desai, T. Urashima, A. Y. Sheikh, R. H. Knutsen, R. P. Mecham, Y. Mishina, et al.
Smooth Muscle Protein 22{alpha}-Mediated Patchy Deletion of Bmpr1a Impairs Cardiac Contractility but Protects Against Pulmonary Vascular Remodeling
Circ. Res., February 15, 2008; 102(3): 380 - 388.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
B. Martinez-Poveda, R. Munoz-Chapuli, S. Rodriguez-Nieto, J. M. Quintela, A. Fernandez, M.-A. Medina, and A. R. Quesada
IB05204, a dichloropyridodithienotriazine, inhibits angiogenesis in vitro and in vivo
Mol. Cancer Ther., October 1, 2007; 6(10): 2675 - 2685.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
O. Pak, A. Aldashev, D. Welsh, and A. Peacock
The effects of hypoxia on the cells of the pulmonary vasculature
Eur. Respir. J., August 1, 2007; 30(2): 364 - 372.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
M. Hinton, A. Gutsol, and S. Dakshinamurti
Thromboxane hypersensitivity in hypoxic pulmonary artery myocytes: altered TP receptor localization and kinetics
Am J Physiol Lung Cell Mol Physiol, March 1, 2007; 292(3): L654 - L663.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
K. R. Stenmark, K. A. Fagan, and M. G. Frid
Hypoxia-Induced Pulmonary Vascular Remodeling: Cellular and Molecular Mechanisms
Circ. Res., September 29, 2006; 99(7): 675 - 691.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. Lee, J. Frischer, A. Serur, J. Huang, J.-O Bae, Z. N. Kornfield, L. Eljuga, C. J. Shawber, N. Feirt, M. Mansukhani, et al.
Inhibition of cyclooxygenase-2 disrupts tumor vascular mural cell recruitment and survival signaling.
Cancer Res., April 15, 2006; 66(8): 4378 - 4384.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
I. R. Preston, N. S. Hill, R. R. Warburton, and B. L. Fanburg
Role of 12-lipoxygenase in hypoxia-induced rat pulmonary artery smooth muscle cell proliferation
Am J Physiol Lung Cell Mol Physiol, February 1, 2006; 290(2): L367 - L374.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
I. Csiki, K. Yanagisawa, N. Haruki, S. Nadaf, J. D. Morrow, D. H. Johnson, and D. P. Carbone
Thioredoxin-1 Modulates Transcription of Cyclooxygenase-2 via Hypoxia-Inducible Factor-1{alpha} in Non-Small Cell Lung Cancer
Cancer Res., January 1, 2006; 66(1): 143 - 150.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
I. N. Bratz and N. L. Kanagy
Nitric oxide synthase-inhibition hypertension is associated with altered endothelial cyclooxygenase function
Am J Physiol Heart Circ Physiol, December 1, 2004; 287(6): H2394 - H2401.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
K. K. K. Sheares, T. K. Jeffery, L. Long, X. Yang, and N. W. Morrell
Differential effects of TGF-{beta}1 and BMP-4 on the hypoxic induction of cyclooxygenase-2 in human pulmonary artery smooth muscle cells
Am J Physiol Lung Cell Mol Physiol, November 1, 2004; 287(5): L919 - L927.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
G. P. Pidgeon, R. Tamosiuniene, G. Chen, I. Leonard, O. Belton, A. Bradford, and D. J. Fitzgerald
Intravascular Thrombosis After Hypoxia-Induced Pulmonary Hypertension: Regulation by Cyclooxygenase-2
Circulation, October 26, 2004; 110(17): 2701 - 2707.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
G. Wu, A. P. Mannam, J. Wu, S. Kirbis, J.-L. Shie, C. Chen, R. J. Laham, F. W. Sellke, and J. Li
Hypoxia induces myocyte-dependent COX-2 regulation in endothelial cells: role of VEGF
Am J Physiol Heart Circ Physiol, December 1, 2003; 285(6): H2420 - H2429.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Crit. Care Med.
Copyright © 2002 American Thoracic Society.